{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:13:34Z","timestamp":1785248014014,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jaut.2022.102815","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:37:29Z","timestamp":1648622249000},"page":"102815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-1563","authenticated-orcid":false,"given":"George A.","family":"Karpouzas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Ormseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102815_bib1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102815_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2796.2010.02260.x","article-title":"Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006","volume":"268","author":"Holmqvist","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2022.102815_bib3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/rheumatology\/key057","article-title":"High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis","volume":"57","author":"Karpouzas","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102815_bib4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics may prevent cardiovascular events in rheumatoid arthritis by Inhibiting coronary plaque formation and stabilizing high-risk lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102815_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2022.102815_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102815_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/jama.284.3.311","article-title":"Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity","volume":"284","author":"Stamler","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2022.102815_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?","volume":"67","author":"Gonzalez","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102815_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102815_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102815_bib11","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.40889","article-title":"Exploring the lipid paradox theory in rheumatoid arthritis: associations of low circulating low-density lipoprotein concentration with subclinical coronary atherosclerosis","volume":"71","author":"Giles","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102815_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2013-204987","article-title":"Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration","volume":"75","author":"Navarro-Mill\u00e1n","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102815_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.39165","article-title":"Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients","volume":"67","author":"Liao","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102815_bib14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/annrheumdis-2017-211708","article-title":"Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis","volume":"76","author":"Robertson","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102815_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1515\/cmble-2015-0020","article-title":"Relationship among IL-6, LDL cholesterol and lipid peroxidation","volume":"20","author":"Lubrano","year":"2015","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jaut.2022.102815_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-020-02307-8","article-title":"Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?","volume":"22","author":"Fern\u00e1ndez-Ortiz","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102815_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.016318","article-title":"Low-density lipoprotein cholesterol corrected for lipoprotein(a) cholesterol, risk thresholds, and cardiovascular events","volume":"9","author":"Willeit","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jaut.2022.102815_bib18","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2022.102815_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2016.10.057","article-title":"SPARCL Trial Investigators, Oxidized phospholipids on apolipoprotein B-100 and recurrent ischemic events following stroke or transient ischemic attack","volume":"69","author":"Byun","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2022.102815_bib20","doi-asserted-by":"crossref","first-page":"3491764","DOI":"10.1155\/2020\/3491764","article-title":"Lipoprotein(a) the insurgent: a new insight into the structure, function, metabolism, pathogenicity, and medications affecting lipoprotein(a) molecule","volume":"2020","author":"Jawi","year":"2020","journal-title":"J. Lipids"},{"key":"10.1016\/j.jaut.2022.102815_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2022.102815_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.21.1.95","article-title":"Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice","volume":"21","author":"Tsimikas","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2022.102815_bib23","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar2129","article-title":"Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2","volume":"9","author":"Lourida","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102815_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2022.102815_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177175","article-title":"Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables","volume":"12","author":"Swainson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102815_bib26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2008.07.031","volume":"52","author":"Budoff","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2022.102815_bib27","first-page":"342","article-title":"SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee","volume":"8","author":"Leipsic","year":"2014","journal-title":"J. Cardiavasc. Comput. Tomogr."},{"key":"10.1016\/j.jaut.2022.102815_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10554-016-0957-2","article-title":"Dynamic change of high-risk plaque detected by coronary computed tomographic angiography in patients with subclinical coronary artery disease","volume":"32","author":"Iwasaki","year":"2016","journal-title":"Int. J. Cardiovasc. Imag."},{"key":"10.1016\/j.jaut.2022.102815_bib29","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1373\/clinchem.2007.091181","article-title":"Ultrasensitive flow-based immunoassays using single-molecule counting","volume":"53","author":"Todd","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jaut.2022.102815_bib30","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3390\/ijms22115880","article-title":"PCSK9 biology and its role in atherothrombosis","volume":"22","author":"Barale","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2022.102815_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-2275(20)40123-3","article-title":"Quantification of cholesterol in all lipoprotein classes by the VAP-II method","volume":"35","author":"Kulkarni","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2022.102815_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0735-1097(00)01180-3","article-title":"Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein","volume":"37","author":"Penny","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2022.102815_bib33","first-page":"93","article-title":"Society of cardiovascular computed tomography\/north American society of cardiovascular imaging - expert consensus document on coronary CT imaging of atherosclerotic plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J. Cardiavasc. Comput. Tomogr."},{"key":"10.1016\/j.jaut.2022.102815_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00296-020-04616-2","article-title":"The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk","volume":"40","author":"Venetsanopoulou","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2022.102815_bib35","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2009.02.041","volume":"53","author":"Fraley","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2022.102815_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(01)00111-6","article-title":"The oxidative modification hypothesis of atherosclerosis: does it hold for humans?","volume":"11","author":"Witztum","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.jaut.2022.102815_bib37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/art.33452","article-title":"Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis","volume":"64","author":"Ishikawa","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102815_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.103.15.1930","article-title":"Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk","volume":"103","author":"Tsimikas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2022.102815_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000040854.47020.44","article-title":"Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation","volume":"22","author":"Fang","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2022.102815_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yl\u00e4-Herttuala","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.jaut.2022.102815_bib41","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1194\/jlr.M600064-JLR200","article-title":"OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages","volume":"47","author":"Saad","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2022.102815_bib42","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis, Cell","volume":"70","author":"Legein","year":"2013","journal-title":"Mol. Life Sci."},{"key":"10.1016\/j.jaut.2022.102815_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neubiorev.2021.06.017","article-title":"The lipid paradox in neuroprogressive disorders: causes and consequences","volume":"128","author":"Morris","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jaut.2022.102815_bib44","first-page":"13","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological role","volume":"31","author":"Tselepis","year":"2018","journal-title":"J Biomed Res"},{"key":"10.1016\/j.jaut.2022.102815_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2019.07.015","article-title":"PCSK9 inhibition and inflammation: a narrative review","volume":"288","author":"Ruscica","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2022.102815_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2016.11.019","article-title":"Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages","volume":"256","author":"Adorni","year":"2017","journal-title":"Atherosclerosis"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:55Z","timestamp":1760257735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":46,"alternative-id":["S0896841122000233"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102815","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102815"}}